The U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday recommended a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with underlying medical conditions that put them at risk of severe disease.
But the panel declined to recommend boosters for younger adults, including healthcare workers, who live or work in institutions with high risk of contracting COVID-19, which could narrow the scope of the U.S. Food and Drug Administration's emergency use authorization https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorize-third-dose-pfizer-covid-19-vaccine-older-americans-bloomberg-2021-09-22 issued on Wednesday.
